Literature DB >> 14688090

Cross-sectional analysis of clinical and environmental isolates of Pseudomonas aeruginosa: biofilm formation, virulence, and genome diversity.

Nathan E Head1, Hongwei Yu.   

Abstract

Chronic lung infections with Pseudomonas aeruginosa biofilms are associated with refractory and fatal pneumonia in cystic fibrosis (CF). In this study, a group of genomically diverse P. aeruginosa isolates were compared with the reference strain PAO1 to assess the roles of motility, twitching, growth rate, and overproduction of a capsular polysaccharide (alginate) in biofilm formation. In an in vitro biofilm assay system, P. aeruginosa displayed strain-specific biofilm formation that was not solely dependent on these parameters. Compared with non-CF isolates, CF isolates expressed two opposing growth modes: reduced planktonic growth versus efficient biofilm formation. Planktonic cells of CF isolates showed elevated sensitivity to hydrogen peroxide, a reactive oxygen intermediate, and decreased lung colonization in an aerosol infection mouse model. Despite having identical genomic profiles, CF sequential isolates produced different amounts of biofilm. While P. aeruginosa isolates exhibited genomic diversity, the genome size of these isolates was estimated to be 0.4 to 19% (27 to 1,184 kb) larger than that of PAO1. To identify these extra genetic materials, random amplification of polymorphic DNA was coupled with PAO1-subtractive hybridization. Three loci were found within the genomes of two CF isolates encoding one novel homolog involved in retaining a Shigella virulence plasmid (mvpTA) and two divergent genes that function in removing negative supercoiling (topA) and biosynthesis of pyoverdine (PA2402). Together, P. aeruginosa biodiversity could provide one cause for the variation of morbidity and mortality in CF. P. aeruginosa may possess undefined biofilm adhesins that are important to the development of an antibiofilm therapeutic target.

Entities:  

Mesh:

Year:  2004        PMID: 14688090      PMCID: PMC343948          DOI: 10.1128/IAI.72.1.133-144.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  56 in total

Review 1.  Genetic analyses of bacterial biofilm formation.

Authors:  L A Pratt; R Kolter
Journal:  Curr Opin Microbiol       Date:  1999-12       Impact factor: 7.934

Review 2.  Biofilm formation as microbial development.

Authors:  G O'Toole; H B Kaplan; R Kolter
Journal:  Annu Rev Microbiol       Date:  2000       Impact factor: 15.500

Review 3.  Bacterial biofilms: a common cause of persistent infections.

Authors:  J W Costerton; P S Stewart; E P Greenberg
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

4.  Initiation of biofilm formation by Pseudomonas aeruginosa 57RP correlates with emergence of hyperpiliated and highly adherent phenotypic variants deficient in swimming, swarming, and twitching motilities.

Authors:  E Déziel; Y Comeau; R Villemur
Journal:  J Bacteriol       Date:  2001-02       Impact factor: 3.490

5.  Identification of a genomic island present in the majority of pathogenic isolates of Pseudomonas aeruginosa.

Authors:  X Liang; X Q Pham; M V Olson; S Lory
Journal:  J Bacteriol       Date:  2001-02       Impact factor: 3.490

6.  Isolation of an Escherichia coli K-12 mutant strain able to form biofilms on inert surfaces: involvement of a new ompR allele that increases curli expression.

Authors:  O Vidal; R Longin; C Prigent-Combaret; C Dorel; M Hooreman; P Lejeune
Journal:  J Bacteriol       Date:  1998-05       Impact factor: 3.490

7.  Genome sequence of enterohaemorrhagic Escherichia coli O157:H7.

Authors:  N T Perna; G Plunkett; V Burland; B Mau; J D Glasner; D J Rose; G F Mayhew; P S Evans; J Gregor; H A Kirkpatrick; G Pósfai; J Hackett; S Klink; A Boutin; Y Shao; L Miller; E J Grotbeck; N W Davis; A Lim; E T Dimalanta; K D Potamousis; J Apodaca; T S Anantharaman; J Lin; G Yen; D C Schwartz; R A Welch; F R Blattner
Journal:  Nature       Date:  2001-01-25       Impact factor: 49.962

8.  Mucoid Pseudomonas aeruginosa in cystic fibrosis: characterization of muc mutations in clinical isolates and analysis of clearance in a mouse model of respiratory infection.

Authors:  J C Boucher; H Yu; M H Mudd; V Deretic
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

9.  Microbial pathogenesis in cystic fibrosis: pulmonary clearance of mucoid Pseudomonas aeruginosa and inflammation in a mouse model of repeated respiratory challenge.

Authors:  H Yu; M Hanes; C E Chrisp; J C Boucher; V Deretic
Journal:  Infect Immun       Date:  1998-01       Impact factor: 3.441

10.  Comparative genome mapping of Pseudomonas aeruginosa PAO with P. aeruginosa C, which belongs to a major clone in cystic fibrosis patients and aquatic habitats.

Authors:  K D Schmidt; B Tümmler; U Römling
Journal:  J Bacteriol       Date:  1996-01       Impact factor: 3.490

View more
  39 in total

1.  Vanadate and triclosan synergistically induce alginate production by Pseudomonas aeruginosa strain PAO1.

Authors:  F Heath Damron; Michael R Davis; T Ryan Withers; Robert K Ernst; Joanna B Goldberg; Guangli Yu; Hongwei D Yu
Journal:  Mol Microbiol       Date:  2011-06-16       Impact factor: 3.501

Review 2.  Targeting bacterial topoisomerase I to meet the challenge of finding new antibiotics.

Authors:  Yuk-Ching Tse-Dinh
Journal:  Future Med Chem       Date:  2015       Impact factor: 3.808

3.  Isolation of Pseudomonas aeruginosa from open ocean and comparison with freshwater, clinical, and animal isolates.

Authors:  Nurul Huda Khan; Yoshikazu Ishii; Noriko Kimata-Kino; Hidetake Esaki; Tomohiko Nishino; Masahiko Nishimura; Kazuhiro Kogure
Journal:  Microb Ecol       Date:  2007-02       Impact factor: 4.552

Review 4.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

5.  Entropically driven aggregation of bacteria by host polymers promotes antibiotic tolerance in Pseudomonas aeruginosa.

Authors:  Patrick R Secor; Lia A Michaels; Anina Ratjen; Laura K Jennings; Pradeep K Singh
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-01       Impact factor: 11.205

6.  Pseudomonas aeruginosa AlgR phosphorylation modulates rhamnolipid production and motility.

Authors:  Yuta Okkotsu; Prince Tieku; Liam F Fitzsimmons; Mair E Churchill; Michael J Schurr
Journal:  J Bacteriol       Date:  2013-10-04       Impact factor: 3.490

7.  Regulated proteolysis controls mucoid conversion in Pseudomonas aeruginosa.

Authors:  Dongru Qiu; Vonya M Eisinger; Donald W Rowen; Hongwei D Yu
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-30       Impact factor: 11.205

8.  Conditions associated with the cystic fibrosis defect promote chronic Pseudomonas aeruginosa infection.

Authors:  Benjamin J Staudinger; Jocelyn Fraga Muller; Skarphéðinn Halldórsson; Blaise Boles; Angus Angermeyer; Dao Nguyen; Henry Rosen; Olafur Baldursson; Magnús Gottfreðsson; Guðmundur Hrafn Guðmundsson; Pradeep K Singh
Journal:  Am J Respir Crit Care Med       Date:  2014-04-01       Impact factor: 21.405

9.  Studies on the involvement of the exopolysaccharide produced by cystic fibrosis-associated isolates of the Burkholderia cepacia complex in biofilm formation and in persistence of respiratory infections.

Authors:  Mónica V Cunha; Sílvia A Sousa; Jorge H Leitão; Leonilde M Moreira; Paula A Videira; Isabel Sá-Correia
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

10.  In situ growth rates and biofilm development of Pseudomonas aeruginosa populations in chronic lung infections.

Authors:  Lei Yang; Janus A J Haagensen; Lars Jelsbak; Helle Krogh Johansen; Claus Sternberg; Niels Høiby; Søren Molin
Journal:  J Bacteriol       Date:  2007-12-21       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.